［1］Fan L，Strasser Weipplk，Li JJ，et al．Breast cancer in China［J］．Lancet Oncol，2014(7)：e279－289.
[2]Chen JL,Fu YY.Apaf- 1 and apoptosis［J］.Foreign Medical Sci Physiol Pathol,2001,8(2):95-97.［陈剑琳,傅宇阳.Apaf- 1和凋亡［J］.国外医学生理病理科学与临床分册,2001,8(2):95-97.］
[3]Yuan S,Topf M,Reubold TF,et al.Changes in Apaf-1 conformation that drive apoptosome assembly［J］.Biochemistry,2013,52:2319-2327.
[4]Pang Y,Bai XC,Yan C,et al.Structure of the apoptosome:Mechanistic insights into activation of an initiator caspase from Drosophila［J］.Genes Dev,2015,29:277-287.
[5]Reubold TF,Eschenburg S.A molecular view on signal transduction by the apoptosome［J］.Cell Signal,2012,24:1420-1425.
[6]Zamzami N,Hirsch T,Dallaporta B,et al.Mitochondrial implicationin accidental and programmed cell death:Apoptosis and necrosis［J］.J Bioenerg Biomembr,1997,29(2):185-193.
[7]Green DR,Kroemer G.The pathophysiology of mitochondrial celldeath［J］.Science,2004,305(5684):626-629.
[8]Zhang BX,Zhang JK，Chen X，et al.Clinical significance of Apaf-1 protein expression in basal cell like breast cancer［J］.Chin Tropical Med,2014,14（9）:1096-1098.［张丙信,张金库,陈雪,等.基底细胞样乳腺癌组织Apaf-1蛋白表达临床意义［J］.中国热带医学,2014,14（9）:1096-1098.］
[9]Ma YG,Lou Y,Zhao HR.Apaf-1 expression and promoter methylation in non small cell lung cancer［J］.Chin J Oncol,2006,13（2）:116-119.［马业罡,娄毅,赵惠儒.非小细胞肺癌组织中Apaf-1基因表达及启动子区甲基化研究［J］.中华肿瘤防治杂志,2006,13（2）:116-119.］
[10]Dong MM.Expression and clinical significance of Apaf-1 gene in hepatocellular carcinoma［D］.Hubei：Huazhong University of Science and Technology,2010.［董明明.Apaf-1基因在肝细胞肝癌中的表达和临床意义［D］.湖北：华中科技大学,2010.］
[11]Liu Z,Zhang CW,Wang C.Methylation and expression of Apaf-1 gene in the occurrence of colorectal cancer［J］.J Qinghai Med College,2010,31（1）:18-23.
[12]Ottosson-Wadlund A,Ceder R,Preta G,et al.Requirement of apoptotic protease activating factor-1 for bortezomib-induced apoptosis but not for Fas-mediated apoptosis in human leukemic cells［J］.Mol Pharmacol,2013,83:245-255.
[13]Soengas MS,Capodieci P,Polsky D,et al.In activation of the apoptosis effect or Apaf-1 in malignant melanoma［J］.Nature,2001,409(6817):207-211.
[14]Fu WN,Bertoni F,Kelsey SM,et al.Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia［J］.Oncogene,2003,22(3):451-455.
[15]Liu XJ,Sun QF，Bian LG，et al.Promoter region methylation of -1 gene promoter and expression of mRNA gene in pituitary adenoma［J］.Chin J Minimally Invasive Neurosurgery,2009,14(4):183-186.［刘先进,孙青芳,卞留贯,等.垂体腺瘤凋亡蛋白酶活化因子-1基因启动子区甲基化与其mRNA表达［J］.中国微侵袭神经外科杂志,2009,14(4):183-186.］
[16]Guo J.The significance of Apaf-1 gene promoter methylation and expression of anti apoptotic protein Apollon in adult acute leukemia［D］.Shandong：Shandong University,2011.［郭军.Apaf-1基因启动子甲基化与抑凋亡蛋白Apollon表达在成人急性白血病发生发展中的意义［D］.山东：山东大学,2011.］
[17]Ma HL,Guo W，Guo YL，et al.Methylation status of apoptotic protease activating factor-1 gene in gastric cardia adenocarcinoma and its clinical significance［J］.Chin J Cancer and Biol Therapy,2012,19（5）:526-530.［马洪亮,郭炜,郭艳丽,等.凋亡蛋白酶活化因子-1基因在贲门腺癌中的甲基化状态及其临床意义［J］.中国肿瘤生物治疗杂志,2012,19（5）:526-530.］
[18]Cecconi F,Alvarez-Bolado G,Meyer BI,et al.Apaf1(CED-4homolog)regulates programmed cell death in mammalian development［J］.Cell,1998,94:727-737.
[19]Yoshida H,Kong YY,Yoshida R,et al.Apaf1 is required for mitochondrial pathways of apoptosis and brain development［J］.Cell,1998,94:7392-7750.
[20]Zlobec I,Minoo P,Baker K,et al.Loss of Apaf-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer［J］.Eur J Cancer,2007,43(6):1101-1107.
[21]Anichini A,Mortarini R,Sensi M,et al.Apaf-1 signaling in human melanoma［J］.Cancer Lett,2006,238(2):168-179.
[22]Perkins C,Kim CN,Fang G,et al.Overexpression of Apaf-1 promotes apoptosis of untreated and paclitaxel-or etopside treated HL-60 cells［J］.Cancer Res,1988，58(20):4561-4566.
[23]Benites BD,Fattori A,Hackel C,et al.Low expression of Apaf-1XL in acute myeloid leukemia may be associated with the failure of remission induction therapy ［J］.Braz J Med Biolres,2008,41(7):571-578.
[24]Li HM,Yang YS,Cheng LF.Transfection of Apaf-1 gene and its effect on the apoptosis of AGS cells induced by 5-FU［J］.Chin J Digestion,2002,22(9):550-553.［李红梅,杨云生,程留芳.Apaf-1基因转染及其对5-氟尿嘧啶诱导AGS细胞凋亡的影响［J］.中华消化杂志,2002,22(9):550-553.］
[25]Zlobec I,Vuong T,Compton C.The predictive value of apoptosis protease-activating factor 1 in rectal tumors treated with preoperative,high-dose-rate brachytherapy［J］.Cancer,2006,106(2):284-286.
[26]Cheng L,Xia TS,Wang YF,et al.The anticancer effect and mechanism of α-hederin on breast cancer cells［J］.Int J Oncol,2014,45:757-763.
[27]Sun JP,Liu JH,Gu H，et al.Effect of arsenic trioxide on the expression of Apaf-1 gene in bladder cancer T24 cells［J］.Carcinogenesis,Teratogenesis and Mutagenesis,2013,25（5）:338-342.［孙军培,刘久华,顾恒,等.三氧化二砷对膀胱癌T24细胞Apaf-1基因表达的影响［J］.癌变·畸变·突变,2013,25（5）:338-342.］
[28]Tan L,Kwok RP,Shukla A,et al.Trichostatin A restores Apaf-1 function in chemoresistant ovarian cancer cells［J］.Cancer，2011，117:784-794.
[29]Pierga JY,Mouret E,Lau rence V,et al.Prognotic factors for survival after neoadjuvant chemotherapy operable breast cancer.The role of clinical response ［J］.Eur J Cancer,2003,39(8):1089-1096.
[30]Liu ZY,Li BJ.Observation of the dynamic changes of circulating tumor cells in neoadjuvant chemotherapy of breast cancer［J］.Clin Oncol China,2015,40(23):1431-1435.［刘志勇，李宝江．乳腺癌新辅助化疗中循环肿瘤细胞的动态变化及疗效观察［Ｊ］．中国肿瘤临床，2015,40(23):1431-1435.］
[31]Berry DA，Cirrincione C，Henderson IC，et al．Estrogen receptor status and outcomes of modern chemotherapy for patients with node positive breast cancer［J］．JAMA，2006，295(14):1658-1667．
[32]Sullivan PS，Apple SK．Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma［J］?Breast J，2009，15(2):146-154.
[33]Nishimura Ｒ，Osako T，Okumura Y，et al．Clinical significance ofKi-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis［J］． Breast Cancer，2010，17(4):269-275．
[34]He Yuping,Xie Yuhui,Kuang Zhongsheng.The relationship between ER,PR,HER2,p53 and neoadjuvant chemotherapy efficacy［J］.Guide of China Med,2012,12(2):401.
[35]Davis DW，Buchholz TA，Hess KR，et al．Automated quantification of apoptosis after neoadjuvant chemotherapy for breast cancer：Early assessment predicts clinical response［J］．Clin Cancer Res，2003，9(3)：955－960.
[36]Ling R,Shi M,Zhang JL,et al.Changes of cell proliferation and apoptosis in breast cancer after neoadjuvant chemotherapy and its clinical significance［J］.Chin J Oncol,2007,14(14):1085-1087.［凌瑞，石梅，张聚良，等．乳腺癌新辅助化疗后细胞增殖与凋亡的变化及临床意义［Ｊ］．中华肿瘤防治杂志，2007,14(14):1085-1087.］
[37]Patil AV，Singhai R,Bhamre RS，et al．Ki-67 biomarker in breast cancer of Indian women［J］.N Am J Med Sci,2011，3（3）：119－128.
[38]Xie M,Chen JF，Liang H，et al.The value of cell apoptosis in prediction of neoadjuvant chemotherapy for breast cancer［J］.Southern China National Medical J,2013,27（12）:870-872.［谢明,陈建发,梁红,等.细胞凋亡对乳腺癌新辅助化疗的预测价值［J］.华南国防医学杂志,2013,27（12）:870-872.］
[39]Del Bello B,Valentini MA,Mangiavacchi P,et al.Role of caspase-3 and-7 in Apaf-1 proteolytic cleavage and degradation even ts during cisplatin-induced apoptosis in melanoma cells［J］.Exp Cell,2004,293(2):302-310.
[40]Arpino G,Ciocca DR，Weiss H,et al．Predictive value of apoptosis，proliferation，HER-2，and topoisomerase II alpha for anthracy cline chemotherapy in locally advanced breast cancer［J］．Breast Cancer Res Treat，2005,92(1):69-75.
[41]Fortin A,Cregan SP,MacLaurin JG,et al.APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death［J］.J Cell Biol,2001,155:207-216.